ORBIMED ADVISORS LLC purchased 313.8% of their position (1.33M shares) of ELECTRA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $20.00M — a major conviction buy. The strongest form of insider conviction signal.
Common Stock
Shares
+2M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.09M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.70M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+333.33K
Price / share
$15.00
Trade value
$5M
% of position
Common Stock
Shares
+758.28K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1M
Price / share
$15.00
Trade value
$15M
% of position
Net shares
+6.89M
Net value
$20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/21/2026 | C · Conversion | +2M | — | — | New position | 0.00 | 2M |
| Common Stock Indirect | 9/21/2026 | C · Conversion | +1.09M | — | — | 54.3% | 2M | 3.09M |
| Common Stock Indirect | 9/21/2026 | C · Conversion | +1.70M | — | — | 55.1% | 3.09M | 4.79M |
| Common Stock Indirect | 9/21/2026 | P · Purchase | +333.33K | $15.00 | $5M | 7.0% | 4.79M | 5.13M |
| Common Stock Indirect | 9/21/2026 | C · Conversion | +758.28K | — | — | New position | 0.00 | 758.28K |
| Common Stock Indirect | 9/21/2026 | P · Purchase | +1M | $15.00 | $15M | 131.9% | 758.28K | 1.76M |
| Total | +6.89M | $20M | ||||||
Series A Convertible Preferred Stock
Common Stock
2M shares
Shares
−2M
Strike price
Held after
0.00
Exercisable
—
Series B Convertible Preferred Stock
Common Stock
1.09M shares
Shares
−1.09M
Strike price
Held after
0.00
Exercisable
—
Series C Convertible Preferred Stock
Common Stock
1.70M shares
Shares
−1.70M
Strike price
Held after
0.00
Exercisable
—
Series C Convertible Preferred Stock
Common Stock
758.28K shares
Shares
−758.28K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock Indirect | Common Stock2M shares | 9/21/2026 | C · Conversion | −2M | — | 0.00 | |
| Series B Convertible Preferred Stock Indirect | Common Stock1.09M shares | 9/21/2026 | C · Conversion | −1.09M | — | 0.00 | |
| Series C Convertible Preferred Stock Indirect | Common Stock1.70M shares | 9/21/2026 | C · Conversion | −1.70M | — | 0.00 | |
| Series C Convertible Preferred Stock Indirect | Common Stock758.28K shares | 9/21/2026 | C · Conversion | −758.28K | — | 0.00 |